- Home
- EKSO vs ABVC Comparison
EKSO vs ABVC Comparison
Compare EKSO & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EKSO | ABVC |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 30.9M |
| IPO Year | 2012 | 2009 |
Fundamental Metrics
Financial Performance| Metric | EKSO | ABVC |
|---|---|---|
| Price | $10.40 | $1.22 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 88.5K | 51.5K |
| Earning Date | 05-04-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.76 | 7.14 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $509,589.00 |
| Revenue This Year | $81.23 | N/A |
| Revenue Next Year | $7.29 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $0.69 |
| 52 Week High | $13.50 | $4.02 |
Technical Indicators
Market Signals| Indicator | EKSO | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 47.11 | 36.05 |
| Support Level | $9.18 | $1.18 |
| Resistance Level | $10.76 | $1.67 |
| Average True Range (ATR) | 1.01 | 0.12 |
| MACD | -0.22 | 0.01 |
| Stochastic Oscillator | 12.79 | 5.88 |
Price Performance
Historical ComparisonAbout EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.